Objective
=========

To characterize bone metabolism in AIS patients using bone metabolism markers.

Summary of background data
==========================

Although osteopenia is often associated with AIS, bone metabolism in this condition has not been assessed.

Methods
=======

Bone mineral density (BMD) of the lumbar spine and bilateral proximal femurs (dual energy x-ray absorptiometry) and bone metabolism markers {bone formation marker: serum bone alkaline phosphatase (BAP); bone resorption marker: serum tartrate-resistant acid phosphatase serum band 5 (TRAP5b)} were measured in 55 consecutive AIS subjects aged 10 to 18 years-old (mean: 15.6+/-1.7). BMD, body mass index (BMI), and age of menarche were compared between subjects with normal and high values of TRAP5b.

Results
=======

Nineteen subjects (34%) had osteopenia and 17 subjects (31%) had osteoporosis. In 51 AIS subjects (93%), values for BAP were within normal range, while 33 subjects (60%) had high values for TRAP5b. Subjects with high values for TRAP5b had BMDs of the lumbar spine significantly lower than BMDs of patients with normal values of TRAP5b.

Conclusions
===========

The primary cause of low BMD in AIS was increased bone resorption.
